Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Apr 2601:30 AM EDT
-02:30 AM EDT
Learn how Keshav, a Chartered Accountant, scored an impressive 705 on GMAT in just 30 days with GMATWhiz's expert guidance. In this video, he shares preparation tips and strategies that worked for him, including the mock, time management, and more.
Apr 2512:30 AM EDT
-01:30 AM EDT
At one point, she believed GMAT wasn’t for her. After scoring 595, self-doubt crept in and she questioned her potential. But instead of quitting, she made the right strategic changes. The result? A remarkable comeback to 695. Check out how Saakshi did it.
Apr 2610:00 AM EDT
-11:00 AM EDT
The Target Test Prep course represents a quantum leap forward in GMAT preparation, a radical reinterpretation of the way that students should study. Try before you buy with a 5-day, full-access trial of the course for FREE!
Apr 2711:00 AM EDT
-12:00 PM EDT
Prefer video-based learning? The Target Test Prep OnDemand course is a one-of-a-kind video masterclass featuring 400 hours of lecture-style teaching by Scott Woodbury-Stewart, founder of Target Test Prep and one of the most accomplished GMAT instructors
Apr 2808:00 AM PDT
-11:00 AM PDT
Whether you are just beginning your MBA journey or fine-tuning your path to a 700+ score, GMAT Day is designed to give you a competitive edge.
May 0111:00 AM PDT
-12:00 PM PDT
Free- full-length test + 15 concept videos + 150+ short videos + study plan!
03 Dec 2025, 01:42
Kudos
Bookmarks
B
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
5%
(low)
Question Stats:
86% (01:13) correct
14%
(01:33)
wrong
based on 254
sessions
History
Date
Time
Result
Not Attempted Yet
Four patients taking the sleeping pill SleepSoon, manufactured by DrugRite, died during a six-month period, yet the government health agency of Country X decided not to remove SleepSoon from the market. Many industry observers were surprised, since the death of so many patient staking a particular drug will often lead to the drug’s being removed from the market.
Which of the following, if true, provides the best indication that the government health agency’s decision was logically well supported?
A. In the previous two-year period, twelve patients taking SleepSoon died, while only two patients taking other sleeping pills died during the same time period.
B. The deaths of the patients taking SleepSoon were found to be unrelated to the sleeping pill SleepSoon.
C. The government health agency of Country X issued new guidelines for drug companies to help standardize the safety criteria that a drug must meet prior to being placed on the market.
D. Consumer groups lobbied for legislation requiring drugs to meet stricter safety standards before being placed on the market.
E. Many DrugRite employees left the company for jobs at other drug manufacturers
Which of the following, if true, provides the best indication that the government health agency’s decision was logically well supported?
A. In the previous two-year period, twelve patients taking SleepSoon died, while only two patients taking other sleeping pills died during the same time period.
B. The deaths of the patients taking SleepSoon were found to be unrelated to the sleeping pill SleepSoon.
C. The government health agency of Country X issued new guidelines for drug companies to help standardize the safety criteria that a drug must meet prior to being placed on the market.
D. Consumer groups lobbied for legislation requiring drugs to meet stricter safety standards before being placed on the market.
E. Many DrugRite employees left the company for jobs at other drug manufacturers
03 Dec 2025, 22:53
Kudos
Bookmarks
Bunuel
There is a medical pill SleepSoon (SS) manufactured by DrugRite, 4 patients died during the 6 month period. The government health agency X did not remove the drug from the market. This left the industry researchers to be surprised, as usually post death due to medication, might cause the drug manufactured to be out of market.
We need to find the logical reason behind the government’s decision.
A. In the previous two-year period, twelve patients taking SleepSoon died, while only two patients taking other sleeping pills died during the same time period.
This provides a comparison between the number of fatalities in the previous two year period due to SS drug intake vs the other sleeping pills. The number of fatalities has been high for the SS drug. This could have been a valid reason to stop this drug. But, the opposite has happened. Hence, wrong.
B. The deaths of the patients taking SleepSoon were found to be unrelated to the sleeping pill SleepSoon.
This sounds more likely to be the answer. As, if the 4 deaths were not due to the drug SS, then the government decision of not banning the drug seems logical. Hence correct answer.
C. The government health agency of Country X issued new guidelines for drug companies to help standardize the safety criteria that a drug must meet prior to being placed on the market.
These are after effects of an event, the government health agency issuing new guidelines for the upcoming medicine launches. But, this doesn’t address the reason why government allowed SS to continue despite deaths.
D. Consumer groups lobbied for legislation requiring drugs to meet stricter safety standards before being placed on the market.
This is same as Option C, aftermath of any major incident. Hence, eliminating it.
E. Many DrugRite employees left the company for jobs at other drug manufacturers.
This option cannot be attributed or linked to government decision. Moreover, the change can be due to personal reasons, or moral responsibility etc. Hence, wrong.
Option B
03 Jan 2026, 06:45
Kudos
Bookmarks
Bunuel
KAPLAN OFFICIAL SOLUTION:
Correct Choice: (B)
If the deaths of the SleepSoon consumers were known to be unrelated to the drug (perhaps they were all diagnosed with cancer), then the deaths would certainly not be reason for the health agency to deny approval. So choice (B) is the best answer.
Choices (A) and (D) provide more evidence for not approving the drug, so these answer choices certainly don’t support the health agency’s decision.
Choice (C) mentions new regulations, but we don’t know whether it would be more be more or less difficult for SleepSoon to receive approval under these guidelines. Choice (E) cannot have any bearing on the approval of the drug by the health agency.
